[Evaluation of the therapeutic efficiency of a new preparation based on betamethasone dipropionate and salicylic acid in a water-alcohol excipient].
D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use*
D004338:Drug Combinations; D012459:Salicylates; C039547:betamethasone dipropionate, salicylic acid drug combination; D001623:Betamethasone
Valutazione dell'efficacia terapeutica di un nuovo preparato a base di betametasone dipropionato e acido salicilico in eccipiente idroalcoolico.